Propofol target-controlled infusion modeling in rabbits: Pharmacokinetic and pharmacodynamic analysis

Jian-yan Chen , Ming Yi , Shang-long Yao , Xue-ping Zhang

Current Medical Science ›› 2016, Vol. 36 ›› Issue (3) : 428 -433.

PDF
Current Medical Science ›› 2016, Vol. 36 ›› Issue (3) : 428 -433. DOI: 10.1007/s11596-016-1604-9
Article

Propofol target-controlled infusion modeling in rabbits: Pharmacokinetic and pharmacodynamic analysis

Author information +
History +
PDF

Abstract

This study aimed to establish a new propofol target-controlled infusion (TCI) model in animals so as to study the general anesthetic mechanism at multi-levels in vivo. Twenty Japanese white rabbits were enrolled and propofol (10 mg/kg) was administrated intravenously. Artery blood samples were collected at various time points after injection, and plasma concentrations of propofol were measured. Pharmacokinetic modeling was performed using WinNonlin software. Propofol TCI within the acquired parameters integrated was conducted to achieve different anesthetic depths in rabbits, monitored by narcotrend. The pharmacodynamics was analyzed using a sigmoidal inhibitory maximal effect model for narcotrend index (NI) versus effect-site concentration. The results showed the pharmacokinetics of propofol in Japanese white rabbits was best described by a two-compartment model. The target plasma concentrations of propofol required at light anesthetic depth was 9.77±0.23 μg/mL, while 12.52±0.69 μg/mL at deep anesthetic depth. NI was 76.17±4.25 at light anesthetic depth, while 27.41±5.77 at deep anesthetic depth. The effect-site elimination rate constant (ke0) was 0.263/min, and the propofol dose required to achieve a 50% decrease in the NI value from baseline was 11.19 μg/mL (95% CI, 10.25–13.67). Our results established a new propofol TCI animal model and proved the model controlled the anesthetic depth accurately and stably in rabbits. The study provides a powerful method for exploring general anesthetic mechanisms at different anesthetic depths in vivo.

Keywords

propofol / target-controlled infusion / modeling / rabbit / pharmacokinetics / pharmacodynamics / anesthetic depth

Cite this article

Download citation ▾
Jian-yan Chen, Ming Yi, Shang-long Yao, Xue-ping Zhang. Propofol target-controlled infusion modeling in rabbits: Pharmacokinetic and pharmacodynamic analysis. Current Medical Science, 2016, 36(3): 428-433 DOI:10.1007/s11596-016-1604-9

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

HussainM, BergerM, EckenhoffRG, et al. . General anesthetic and the risk of dementia in elderly patients: current insights. Clin Interv Aging, 2014, 9: 1619-1628 PMID: 25284995 PMCID: 4181446

[2]

BaoticI, WeihrauchD, ProcknowJ, et al. . Isoflurane favorably modulates guanosine triphosphate cyclohydrolase-1 and endothelial nitric oxide synthase during myocardial ischemia and reperfusion injury in rats. Anesthesiology, 2015, 123(3): 582-589 PMID: 26192027

[3]

LiQ, LuJ, WangX. Propofol and remifentanil at moderate and high concentrations affect proliferation and differentiation of neural stem/progenitor cells. Neural Regen Res, 2014, 9(22): 2002-2007 PMID: 25598783 PMCID: 4283284

[4]

JiangYX, DaiZL, ZhangXP, et al. . Dexmedetomidine alleviates pulmonary edema by upregulating AQP1 and AQP5 expression in rats with acute lung injury induced by lipopolysaccharide. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(5): 684-688 PMID: 26489622

[5]

XiongM, da GracaRL, LiJ, et al. . Blockade of brain γ-aminobutyric acid A receptors antagonizes hypnotic action of isoflurane in rats?GABA receptor and isoflurane induced hypnosis. J Behav Brain Sci, 2011, 1(3): 188-193

[6]

GuoZG, JiaXP, WangXY, et al. . Bispectral index for monitoring anesthetic depth in patients with severe burns receiving target-controlled infusion of remifentanil and propofol. Genet Mol Res, 2015, 14(3): 7597-7604 PMID: 26214438

[7]

KatochS, VermaL, SharmaM, et al. . Experimental study of the pathogenicity of pasteurella multocida capsular type B in rabbits. J Comp Pathol, 2015, 153(2-3): 160-166 PMID: 26220707

[8]

SaraghiM, BadnerVM, GoldenLR, et al. . Propofol: an overview of its risks and benefits. Compend Contin Educ Dent, 2013, 34(4): 252-258 PMID: 23895562

[9]

GrossherrM, SpiesE, ScheelA, et al. . Differences of propofol concentrations in mammalian whole blood and in corresponding plasma samples analyzed by high performance liquid chromatography. Clin Lab, 2007, 53(5-6): 315-319 PMID: 17605407

[10]

ShenJ, LiS, BowsherRR, et al. . Using DTA and DTAARRAY variables and programming in WinNonlin ASCII models to streamline user-defined calculation and data analysis. AAPS J, 2015, 17(2): 474-478 PMID: 25583216 PMCID: 4365079

[11]

PuriA, MedhiB, PandaNB, et al. . Propofol pharmacokinetics in young healthy Indian subjects. Indian J Pharmacol, 2012, 44(3): 402-406 PMID: 22701256 PMCID: 3371469

[12]

YamadaA, KajiiY, SakaiS, et al. . Effects of chewing and swallowing behavior on jaw opening reflex responses in freely feeding rabbits. Neurosci Lett, 2013, 535(6): 73-77 PMID: 23313598

[13]

HillAV. The possible effect of the aggregation of the molecules of hemoglobin on its dissociation curves. J Physiol, 1910, 40: 4-7

[14]

CortínezLI, De la FuenteN, EleveldDJ, et al. . Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis. Anesth Analg, 2014, 119(2): 302-310 PMID: 24977639

[15]

PrzybylowskiK, TyczkaJ, SzczesnyD, et al. . Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery. J Pharmacokinet Pharmacodyn, 2015, 42(2): 111-122 PMID: 25628234 PMCID: 4355445

[16]

Miyabe-NishiwakiT, MasuiK, KanekoA, et al. . Hypnotic effects and pharmacokinetics of a single bolus dose of propofol in Japanese macaques (Macaca fuscata fuscata). Vet Anaesth Analg, 2010, 37(6): 501-510 PMID: 21040374

[17]

LeeSH, KangHJ, JinSJ, et al. . Impact of aminophylline on the pharmacodynamics of propofol in beagle dogs. J Pharmacokinet Pharmacodyn, 2014, 41(6): 599-612 PMID: 25150710

[18]

AdamHK, GlenJB, HoylePA. Pharmacokinetics in laboratory animals of ICI 35 868, a new i.v. anaesthetic agent. Br J Anaesth, 1980, 52(8): 743-746 PMID: 6968566

[19]

GuoZ, PangL, JiaX, et al. . Intraoperative target-controlled infusion anesthesia application using remifentanil hydrochloride with etomidate in patients with severe burn as monitored using Narcotrend. Burns, 2015, 41(1): 100-105 PMID: 24931823

[20]

YangXY, ZhouZB, YangL, et al. . Hemodynamic responses during induction: comparison of Marsh and Schnider pharmacokinetic models. Int J Clin Pharmacol Ther, 2015, 53(1): 32-40 PMID: 25500489

[21]

Bon-nyeoKOO, Jeong-rimLEE, Gyu-jeongNOH, et al. . A pharmacodynamic analysis of factors affecting recovery from anesthesia with propofol-remifentanil target controlled infusion. Acta Pharmacologica Sinica, 2012, 33(8): 1080-1084

[22]

TachibanaN, NiiyamaY, YamakageM. Evaluation of bias in predicted and measured propofol concentrations during target-controlled infusions in obese Japanese patients: an open-label comparative study. Eur J Anaesthesiol, 2014, 31(12): 701-707 PMID: 25192266

[23]

SigmondN, BaechtoldM, SchumacherPM, et al. . Pharmacokinetic parameter sets of alfentanil revisited: optimal parameters for use in target controlled infusion and anaesthesia display systems. Br J Anaesth, 2013, 111(2): 197-208 PMID: 23512864

AI Summary AI Mindmap
PDF

99

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/